The rare post-Covid illness hospitalising 100 children a week
NHS bosses preparing for feared surge in cases of paediatric inflammatory multi-system syndrome
NHS hospitals are freeing up intensive care beds in preparation for an expected increase in cases of a rare disease triggered by Covid-19 that is already hospitalising up to 100 children a week.
Paediatric inflammatory multi-system syndrome (PIMS) is a post-viral syndrome that “one in 5,000 children get about a month after having Covid, regardless of whether they had symptoms”, The Guardian reports.
According to the NHS website, symptoms include a high temperature that lasts for a few days; a rash; abdominal pain; tiredness or weakness; red and cracked lips; and diarrhoea and vomiting. In serious cases, the symptoms are like those of toxic shock, sepsis or Kawasaki disease, another rare condition affecting children and infants.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Guardian says that in a “phenomenon that is worrying paediatricians”, hospital admission figures seen by the paper show that 75% of children worst impacted by PIMS are black, asian or minority ethnic (BAME).
And in another major cause for concern, “experts believe they will see a larger number of children affected by the disease” in the coming weeks, “because of how widespread Covid-19 infections have become in the last month”, The Independent reports.
“Paediatric departments across the NHS are recalling children’s nurses who have been redeployed to help care for adult patients”, while also “freeing up specialist intensive care beds”, as more cases of the rare illness are reported, the paper continues.
The mother of a seven-year-old girl told Metro in January about how her daughter was rushed to hospital after developing PIMS weeks after a coronavirus outbreak at her school.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Debbie McGuire, from Grimsby, raised the alert after noticing that daughter Sienna’s lips had turned bright red and that she had a rash on both hands.
Sienna was taken to a local hospital, where she was put on a course of antibiotics through a drip, “but her temperature rose to 39.5C and she could barely stay awake”, according to the paper.
As her condition continued to deteriorate, the schoolgirl was transferred to Sheffield Children’s Hospital the following day.
“The consultant explained to me that she suspected Sienna had something called Paediatric Multi-System Inflammatory Syndrome which is related to Covid-19 and causes inflammation around the body, and can cause tissue damage or organ failure,” her mother recalled, adding: “I was so scared of losing her at that point.”
Fortunately, Sienna’s condition improved and she is now back at home.
Dr Liz Whittaker, infectious disease lead at the Royal College of Paediatrics and Child Health (RCPCH), says that “PIMS can be very serious”, but is urging parents not to panic.
The condition “remains rare”, Whittaker said, adding: “We don’t think parents should worry, as it is far more likely not to affect their child than to affect them.”
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
Will Biden's AI rules keep the genie in the bottle?
Talking Points A new blow in the race for 'geopolitical superiority'
By Joel Mathis, The Week US Published
-
Israel and Hamas reach long awaited Gaza ceasefire
The Explainer After more than a year of violence that has left tens of thousands dead and pushed the Middle East toward broader regional war, negotiators say an end is in sight
By Rafi Schwartz, The Week US Published
-
Hang 10 at El Zonte, a surfer's paradise in El Salvador
The Week Recommends Catch some waves and a great cup of coffee
By Catherine Garcia, The Week US Published
-
The UK's first legal drug consumption room
The Explainer 'Potentially transformative moment in UK drugs policy' as The Thistle opens in Glasgow
By The Week UK Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
How can the UK solve the adult social care crisis?
Today's Big Question New commission announced to turn our buckling care sector around: yet more delay or finally a way forward?
By Elizabeth Carr-Ellis, The Week UK Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Should blood donors be paid?
The Explainer Financial rewards would help fill NHS shortfall but bring risk of contamination and exploitation, WHO warns
By The Week UK Published
-
UK gynaecological care crisis: why thousands of women are left in pain
The Explainer Waiting times have tripled over the past decade thanks to lack of prioritisation or funding for women's health
By Harriet Marsden, The Week UK Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published